 |
Bendamustine oral doseage formulation |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-05 00:00:00 |
| Sponsor | Exinda Theapeutics LLC;8430 Rovana Circle, Suite B;Sacramento, California, 95828 |
| |
Bendamustine oral doseage formulation |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-05 00:00:00 |
| Sponsor | Exinda Theapeutics LLC;8430 Rovana Circle, Suite B;Sacramento, California, 95828 |